222 related articles for article (PubMed ID: 2407959)
1. Preliminary report of the Stroke Prevention in Atrial Fibrillation Study.
Stroke Prevention in Atrial Fibrillation Study Group Investigators
N Engl J Med; 1990 Mar; 322(12):863-8. PubMed ID: 2407959
[TBL] [Abstract][Full Text] [Related]
2. Stroke Prevention in Atrial Fibrillation Study. Final results.
Circulation; 1991 Aug; 84(2):527-39. PubMed ID: 1860198
[TBL] [Abstract][Full Text] [Related]
3. Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study.
Lancet; 1994 Mar; 343(8899):687-91. PubMed ID: 7907677
[TBL] [Abstract][Full Text] [Related]
4. A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement.
Turpie AG; Gent M; Laupacis A; Latour Y; Gunstensen J; Basile F; Klimek M; Hirsh J
N Engl J Med; 1993 Aug; 329(8):524-9. PubMed ID: 8336751
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.
Arch Intern Med; 1994 Jul; 154(13):1449-57. PubMed ID: 8018000
[TBL] [Abstract][Full Text] [Related]
6. Progress report of the Stroke Prevention in Atrial Fibrillation Study.
Anderson DC
Stroke; 1990 Nov; 21(11 Suppl):III12-7. PubMed ID: 2237968
[TBL] [Abstract][Full Text] [Related]
7. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.
Ezekowitz MD; Bridgers SL; James KE; Carliner NH; Colling CL; Gornick CC; Krause-Steinrauf H; Kurtzke JF; Nazarian SM; Radford MJ
N Engl J Med; 1992 Nov; 327(20):1406-12. PubMed ID: 1406859
[TBL] [Abstract][Full Text] [Related]
8. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation.
; Singer DE; Hughes RA; Gress DR; Sheehan MA; Oertel LB; Maraventano SW; Blewett DR; Rosner B; Kistler JP
N Engl J Med; 1990 Nov; 323(22):1505-11. PubMed ID: 2233931
[TBL] [Abstract][Full Text] [Related]
9. Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.
Arch Intern Med; 1996 Feb; 156(4):409-16. PubMed ID: 8607726
[TBL] [Abstract][Full Text] [Related]
10. [Atrial fibrillation and apoplexy--risks and prevention].
Koefoed BG; Gulløv AL; Petersen P
Nord Med; 1996 Jun; 111(6):171-5. PubMed ID: 8700641
[TBL] [Abstract][Full Text] [Related]
11. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group.
Lancet; 1993 Nov; 342(8882):1255-62. PubMed ID: 7901582
[TBL] [Abstract][Full Text] [Related]
12. [The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin].
Hu DY; Zhang HP; Sun YH; Jiang LQ;
Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Apr; 34(4):295-8. PubMed ID: 16776915
[TBL] [Abstract][Full Text] [Related]
13. Design of a multicenter randomized trial for the Stroke Prevention in Atrial Fibrillation Study. The Stroke Prevention in Atrial Fibrillation Investigators.
Stroke; 1990 Apr; 21(4):538-45. PubMed ID: 2183405
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators.
Arch Intern Med; 1997 Jun; 157(11):1237-40. PubMed ID: 9183235
[TBL] [Abstract][Full Text] [Related]
15. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.
Petersen P; Boysen G; Godtfredsen J; Andersen ED; Andersen B
Lancet; 1989 Jan; 1(8631):175-9. PubMed ID: 2563096
[TBL] [Abstract][Full Text] [Related]
16. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Go AS; Hylek EM; Chang Y; Phillips KA; Henault LE; Capra AM; Jensvold NG; Selby JV; Singer DE
JAMA; 2003 Nov; 290(20):2685-92. PubMed ID: 14645310
[TBL] [Abstract][Full Text] [Related]
17. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial.
Lancet; 1996 Sep; 348(9028):633-8. PubMed ID: 8782752
[TBL] [Abstract][Full Text] [Related]
18. [Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S; Trappolini M; Chillotti FM
Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
[TBL] [Abstract][Full Text] [Related]
19. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.
Hart RG; Benavente O; McBride R; Pearce LA
Ann Intern Med; 1999 Oct; 131(7):492-501. PubMed ID: 10507957
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of coumadin and aspirin for primary cardioembolic stroke and thromboembolic preventions of chronic rheumatic mitral stenosis with atrial fibrillation.
Poungvarin N; Opartkiattikul N; Chaithiraphan S; Viriyavejakul A
J Med Assoc Thai; 1994 Jan; 77(1):1-6. PubMed ID: 7798824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
